Cabozantinib for Advanced Urothelial Cancer

Clinical trial NCT01688999 · COMPLETED

Trial details

NCT number: NCT01688999
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma Urethral Neoplasms Urinary Bladder Neoplasms Kidney Neoplasms

Start date: 2012-09-11
Primary completion: 2017-12-11
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.